Genomics, Risk, and Health Decision-Making Laboratory The mission of the Genomics, Risk, and Health Decision-Making Laboratory, launched in 2016 at Memorial Sloan Kettering Cancer Center, is to optimize the translation of novel discoveries regarding cancer risk and genomics into clinical practice. Our research concerns cancer risk perceptions and health decision-making in patients, families, healthcare providers, and members of the general public across diverse populations and settings.